| __timestamp | Intra-Cellular Therapies, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 31354781 |
| Thursday, January 1, 2015 | 87718074 | 43445817 |
| Friday, January 1, 2016 | 93831530 | 66489820 |
| Sunday, January 1, 2017 | 79419009 | 96886134 |
| Monday, January 1, 2018 | 132166913 | 153793000 |
| Tuesday, January 1, 2019 | 89124838 | 148369000 |
| Wednesday, January 1, 2020 | 65782137 | 151934000 |
| Friday, January 1, 2021 | 88845513 | 198532000 |
| Saturday, January 1, 2022 | 134715000 | 112128000 |
| Sunday, January 1, 2023 | 180142000 | 76192000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Intra-Cellular Therapies, Inc. increased its R&D expenses by over 750%, peaking in 2023. This surge underscores their strategic focus on developing groundbreaking treatments.
Similarly, TG Therapeutics, Inc. saw a substantial rise in R&D spending, with a notable peak in 2021. Despite a slight decline in recent years, their investment remains robust, highlighting their ongoing commitment to innovation.
These trends reveal the dynamic nature of the biotech industry, where sustained R&D investment is pivotal for long-term success.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending